Schumer Demanded FDA Probe Into Illicit Chinese Vapes

Senator Chuck Schumer has called for an investigation into unauthorized nicotine products flooding the U.S. market.

Updated on Sept. 27, 2026 in Asthma

Bold flat-color editorial illustration showing a single stylized vaporizing device, representing regulatory oversight of nicotine products. — Senator Chuck Schumer has formally requested the FDA launch an investigation into the prevalence and distribution of illicit, unauthorized Chinese-manufactured e-cigarettes in the U.S. AI Illustration. Upload story photo >

Live Poll

Should the federal government increase regulation of imported electronic cigarettes and nicotine products?

Senator Chuck Schumer requested a formal report from the FDA regarding the prevalence of illicit Chinese-manufactured e-cigarettes. He demanded that the agency explain how it plans to identify and remove these unauthorized products from the U.S. market.

Why it matters

There is significant concern that unauthorized vaping products are specifically designed to appeal to youth. Additionally, lawmakers worry that 2025 FDA staffing cuts have severely limited the agency's ability to police the influx of these products.

Approximately 70% of all e-cigarette sales in the U.S. are unauthorized, with that figure rising to 97% for disposable units. The FDA is currently expected to provide a formal response to these findings within 30 days.

The players

Chuck Schumer

He is a United States Senator who serves as the senior senator from New York.

Kyle Diamantas

He is the acting commissioner of the Food and Drug Administration.

Food and Drug Administration

This is a federal agency responsible for protecting public health by ensuring the safety and security of tobacco products and drugs.

The details

In a two-page letter to FDA acting commissioner Kyle Diamantas, Senator Schumer requested an investigation into whether Chinese manufacturers are using chemical substitutes to bypass regulatory requirements. The Senator is pushing the FDA to utilize its existing authority to stop the distribution of these illicit goods.

In 2025, the Trump administration implemented staffing cuts to the FDA.
On September 27, 2026, the report regarding illicit vape sales was initiated.
By October 27, 2026, the FDA is expected to provide a formal response to the request.

The Big Picture

The current oversight struggle follows the implementation of the 2025 FDA staffing cuts, which critics argue have fundamentally weakened the agency's enforcement capabilities. This inquiry serves as a direct legislative challenge to the efficacy of the FDA under those reduced staffing levels.

Consumers should be aware that a vast majority of disposable e-cigarettes on the market lack official regulatory authorization. This poses potential health risks for users due to the use of unverified chemical substances in knockoff products.

The takeaway

The surge in unauthorized vaping products highlights a significant gap in federal oversight following recent administrative budget changes. Consumers are encouraged to verify the legitimacy of nicotine products to avoid exposure to unregulated chemical compounds.